Cell Health Assays with the acumen® Cellista
17 December 2014
Dr Paul Wylie, senior applications scientist, TTP Labtech, discusses the importance of cell health assays to today's screeners. This is due to the pressing need to fail toxic compounds at an earlier - and less expensive - stage in the drug discovery process. The key challenge is to get more relevant, robust high content data at a suitable early stage to build a stronger drug pipeline.